- Home
- WATT vs CARM Comparison
WATT vs CARM Comparison
Compare WATT & CARM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WATT
- CARM
- Stock Information
- Founded
- WATT 2012
- CARM 2016
- Country
- WATT United States
- CARM United States
- Employees
- WATT N/A
- CARM N/A
- Industry
- WATT Radio And Television Broadcasting And Communications Equipment
- CARM Biotechnology: Pharmaceutical Preparations
- Sector
- WATT Technology
- CARM Health Care
- Exchange
- WATT Nasdaq
- CARM Nasdaq
- Market Cap
- WATT 9.9M
- CARM 8.4M
- IPO Year
- WATT 2014
- CARM N/A
- Fundamental
- Price
- WATT $0.28
- CARM $0.42
- Analyst Decision
- WATT
- CARM Hold
- Analyst Count
- WATT 0
- CARM 5
- Target Price
- WATT N/A
- CARM $0.90
- AVG Volume (30 Days)
- WATT 569.9K
- CARM 42.1M
- Earning Date
- WATT 08-07-2025
- CARM 08-07-2025
- Dividend Yield
- WATT N/A
- CARM N/A
- EPS Growth
- WATT N/A
- CARM N/A
- EPS
- WATT N/A
- CARM N/A
- Revenue
- WATT $1,047,000.00
- CARM $19,964,000.00
- Revenue This Year
- WATT $1,028.91
- CARM N/A
- Revenue Next Year
- WATT N/A
- CARM N/A
- P/E Ratio
- WATT N/A
- CARM N/A
- Revenue Growth
- WATT 137.41
- CARM 32.45
- 52 Week Low
- WATT $0.12
- CARM $0.14
- 52 Week High
- WATT $2.70
- CARM $1.90
- Technical
- Relative Strength Index (RSI)
- WATT 52.37
- CARM 52.02
- Support Level
- WATT $0.25
- CARM $0.41
- Resistance Level
- WATT $0.29
- CARM $0.56
- Average True Range (ATR)
- WATT 0.02
- CARM 0.13
- MACD
- WATT 0.00
- CARM -0.01
- Stochastic Oscillator
- WATT 60.00
- CARM 20.33
About WATT Energous Corporation
Energous Corp has developed wireless power networks technology (WPNT), consisting of semiconductor chipsets, software controls, hardware designs, and antennas, that enable radio frequency (RF) based charging for Internet of Things (IoT) devices. The WPN technology provides a comprehensive suite of capabilities designed to power the next generation of wireless energy networks, seamlessly delivering power and data across diverse, battery-free device ecosystems. It enhances operational visibility, control, and intelligent business automation. Its products include Transmitter IC & Module, Receivers IC, Transmitter System, and Evaluation Kits.
About CARM Carisma Therapeutics Inc.
CARISMA Therapeutics Inc is a clinical-stage cell therapy company focused on utilizing Carisma's proprietary chimeric antigen receptor macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. The company has created a comprehensive cell therapy platform to enable the therapeutic use of engineered macrophages and monocytes, which belong to a subgroup of white blood cells called myeloid cells.